Lynda G Littlefield

Title: Lynda G. Littlefield: Innovator in Cancer Research

Introduction

Lynda G. Littlefield, an accomplished inventor based in Clinton, TN, has made significant contributions to the field of cancer research. With a focus on innovative methodologies for developing cancer cell lines, her work is a testament to the strides being made in medical science.

Latest Patents

Lynda holds a patent for her invention titled "Continuous cell-line tamarin adenocarcinoma of the colon." This groundbreaking invention is specifically related to a continuous cell-line of tamarin adenocarcinoma derived from the species Saquinus oedipus oedipus, designated as TAC-1. The patent outlines a method for establishing an adenocarcinoma cell-line, which involves obtaining a sample of a colorectal tumor, mincing, incubating, and subculturing the sample. Moreover, it includes methods for the serial passage of the cell-line and specifies a suitable medium for its maintenance.

Career Highlights

Lynda is associated with Oak Ridge Associated Universities, an organization that fosters research and collaboration among academic, industry, and governmental partners. Her position allows her to engage in groundbreaking research and contribute to significant advancements in cancer treatments.

Collaborations

Among her notable collaborators is Shirley P. Colyer, who has been an integral part of Lynda's research efforts. Together, they have contributed to enhancing our understanding of cancer biology and developing innovative solutions aimed at improving patient outcomes.

Conclusion

Lynda G. Littlefield's work exemplifies the vital role of innovation in medical research. Her dedication to developing new methodologies for cancer research continues to pave the way for future advancements in the field. Through her patent and collaborative efforts, Lynda is making strides that hold the promise of improving cancer treatments and patient care.